Improving long-term outcome in allograft transplantation: Role of ionic composition and polyethylene glycol

Transplantation

Volumn 91, Issue 6, 2011, Pages 605-614

  Thuillier, Raphael ^a,b,c   Giraud, Sebastien ^a,b,c   Favreau, Frederic ^a,b,c   Goujon, Jean Michel ^a   Desurmont, Thibault ^a   Eugene, Michel ^a,c,d   Barrou, Benoit ^a,c,e,f   Hauet, Thierry ^a,b,c,d  

^a UNIVERSITÉ DE POITIERS   (France)

^b CHUde Poitiers ^*  (France)

^c FLIRT: Federation Pour l'Etude de l'Ischemie Reperfusion en Transplantation   (France)

^d CEMAGREF   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f SORBONNE UNIVERSITÉ   (France)

Author keywords

Graft outcome; Hypoxia; Immune response; Interstitial fibrosis; Ischemia reperfusion injury; Kidney preservation

Indexed keywords

HETASTARCH; MACROGOL; POTASSIUM; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; CELL VIABILITY; COLLOID; CONTROLLED STUDY; ENDOTHELIUM CELL; FOLLOW UP; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; ISCHEMIA; KIDNEY FIBROSIS; KIDNEY TRANSPLANTATION; MALE; NONHUMAN; ORGAN PRESERVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; SURVIVAL; SWINE;

ADAPTIVE IMMUNITY; ANIMALS; IMMUNITY, INNATE; KIDNEY TRANSPLANTATION; MALE; ORGAN PRESERVATION SOLUTIONS; POLYETHYLENE GLYCOLS; REPERFUSION INJURY; SWINE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 79952769244     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182090fa3     Document Type: Article

References (62)

1. Meier-Kriesche HU, Schold JD, Srinivas TR, et al. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378.
2. Simmons MN, Schreiber MJ, Gill IS. Surgical renal ischemia: A contemporary overview. J Urol 2008; 180: 19.
3. Favreau F, Thuillier R, Cau J, et al. Anti-thrombin therapy during warm ischemia and cold preservation prevents chronic kidney graft fibrosis in a DCD model. Am J Transplant 2010; 10: 30.
4. Dragun D, Hoff U, Park JK, et al. Ischemia-reperfusion injury in renal transplantation is independent of the immunologic background. Kidney Int 2000; 58: 2166.
5. Cassie S, Masterson MF, Polukoshko A, et al. Ischemia/reperfusion induces the recruitment of leukocytes from whole blood under flow conditions. Free Radic Biol Med 2004; 36: 1102.
6. Salahudeen AK. Cold ischemic injury of transplanted organs: Some new strategies against an old problem. Am J Transplant 2004; 4: 1. (Pubitemid 38155482)
7. Jayle C, Favreau F, Zhang K, et al. Comparison of protective effects of trimetazidine against experimental warm ischemia of different durations: Early and long-term effects in a pig kidney model. Am J Physiol Renal Physiol 2007; 292: F1082.
8. Rauen U, de Groot H. New insights into the cellular and molecular mechanisms of cold storage injury. J Investig Med 2004; 52: 299.
9. Brodsky SV, Yamamoto T, Tada T, et al. Endothelial dysfunction in ischemic acute renal failure: Rescue by transplanted endothelial cells. Am J Physiol Renal Physiol 2002; 282: F1140.
10. Maathuis MH, Leuvenink HG, Ploeg RJ. Perspectives in organ preservation. Transplantation 2007; 83: 1289.
11. Salahudeen AK. Cold ischemic injury of transplanted kidneys: New insights from experimental studies. Am J Physiol Renal Physiol 2004; 287: F181.
12. Huter L, Simon TP, Weinmann L, et al. Hydroxyethylstarch impairs renal function and induces interstitial proliferation, macrophage infiltration and tubular damage in an isolated renal perfusion model. Crit Care 2009; 13: R23.
13. Hauet T, Eugene M. A new approach in organ preservation: Potential role of new polymers. Kidney Int 2008; 74: 998.
14. Le Y, Scott MD. Immunocamouflage: The biophysical basis of immunoprotection by grafted methoxypoly(ethylene glycol) (mPEG). Acta Biomater 2010; 6: 2631.
15. Collins GM, Wicomb WN, Levin BS, et al. Heart preservation solution containing polyethyleneglycol: An immunosuppressive effect? Lancet 1991; 338: 890.
16. Ben Abdennebi H, El Rassi Z, Steghens JP, et al. Effective pig liver preservation with an extracellular-likeUWsolution containing the oncotic agent polyethylene glycol: A preliminary study. Transplant Proc 2002; 34: 762.
17. Tokunaga Y, Wicomb WN, Garcia-Kennedy R, et al. The immunosuppressive effect of polyethylene glycol in a flush solution for rat liver transplantation. Transplantation 1992; 54: 756.
18. Zheng TL, Lanza RP, Soon-Shiong P. Prolonged pancreas preservation using a simplified UW solution containing polyethylene glycol. Transplantation 1991; 51: 63.
19. Giraud S, Hauet T, Eugene M, et al.Anew preservation solution (SCOT 15) improves the islet isolation process from pancreata of non-heartbeating donors: A murine model. Transplant Proc 2009; 41: 3293.
20. Wee YM, Lim DG, Kim YH, et al. Cell surface modification by activated polyethylene glycol prevents allosensitization after islet transplantation. Cell Transplant 2008; 17: 1257.
21. Weber LM, Cheung CY, Anseth KS. Multifunctional pancreatic islet encapsulation barriers achieved via multilayer PEG hydrogels. Cell Transplant 2008; 16: 1049.
22. Itasaka H, Burns W, Wicomb WN, et al. Modification of rejection by polyethylene glycol in small bowel transplantation. Transplantation 1994; 57: 645.
23. Jayle C, Corbi P, Eugene M, et al. Beneficial effect of polyethylene glycol in lung preservation: Early evaluation by proton nuclear magnetic resonance spectroscopy. Ann Thorac Surg 2003; 76: 896.
24. Bradley AJ, Murad KL, Regan KL, et al. Biophysical consequences of linker chemistry and polymer size on stealth erythrocytes: Size does matter. Biochim Biophys Acta 2002; 1561: 147.
25. Scott MD, Murad KL, Koumpouras F, et al. Chemical camouflage of antigenic determinants: Stealth erythrocytes. Proc Natl Acad Sci USA 1997; 94: 7566.
26. Murad KL, Gosselin EJ, Eaton JW, et al. Stealth cells: Prevention of major histocompatibility complex class II-mediated T-cell activation by cell surface modification. Blood 1999; 94: 2135.
27. Eugene M, Hauet T, Mothes D, et al. Beneficial effects of a lowpotassium and polyethylene glycol solution on renal function and structure during 48-hour cold storage preservation. Transplant Proc 1997; 29: 2360.
28. Faure JP, Petit I, Zhang K, et al. Protective roles of polyethylene glycol and trimetazidine against cold ischemia and reperfusion injuries of pig kidney graft. Am J Transplant 2004; 4: 495.
29. Hauet T, Goujon JM, Baumert H, et al. Polyethylene glycol reduces the inflammatory injury due to cold ischemia/reperfusion in autotransplanted pig kidneys. Kidney Int 2002; 62: 654.
30. Hauet T, Baumert H, Amor IB, et al. Protection of autotransplanted pig kidneys from ischemia-reperfusion injury by polyethylene glycol. Transplantation 2000; 70: 1569.
31. Hauet T, Baumert H, Faure JP, et al. Beneficial effects of low-potassium and polyethylene glycol solution on renal lipid peroxidation during 48-hour cold storage and normothermic reperfusion. Transplant Proc 1998; 30: 2798.
32. Faure JP, Hauet T, Han Z, et al. Polyethylene glycol reduces early and long-term cold ischemia-reperfusion and renal medulla injury. J Pharmacol Exp Ther 2002; 302: 861.
33. Codas R, Petruzzo P, Morelon E, et al. IGL-1 solution in kidney transplantation: First multi-center study. Clin Transplant 2009; 23: 337.
34. Dutheil D, Rioja-Pastor I, Tallineau C, et al. Protective effect of PEG 35,000 Da on renal cells: Paradoxical activation of JNK signaling pathway during cold storage. Am J Transplant 2006; 6: 1529.
35. Franco-Gou R, Mosbah IB, Serafin A, et al. New preservation strategies for preventing liver grafts against cold ischemia reperfusion injury. J Gastroenterol Hepatol 2007; 22: 1120.
36. Scott MD, Murad KL. Cellular camouflage: Fooling the immune system with polymers. Curr Pharm Des 1998; 4: 423.
37. El-Zoghby ZM, Stegall MD, Lager DJ, et al. Identifying specific causes of kidney allograft loss. Am J Transplant 2009; 9: 527.
38. Wang W, Koka V, Lan HY. Transforming growth factor-beta and Smad signalling in kidney diseases. Nephrology (Carlton) 2005; 10: 48.
39. Banasik M, Klinger M. Chronic allograft nephropathy-immunologic and nonimmunologic factors. Ann Transplant 2006; 11: 7.
40. Liu Y. New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 2010; 21: 212.
41. Djamali A, Reese S, Yracheta J, et al. Epithelial-to-mesenchymal transition and oxidative stress in chronic allograft nephropathy. Am J Transplant 2005; 5: 500.
42. Vongwiwatana A, Tasanarong A, Rayner DC, et al. Epithelial to mesenchymal transition during late deterioration of human kidney transplants: The role of tubular cells in fibrogenesis.AmJ Transplant 2005; 5: 1367.
43. Bedi S, Vidyasagar A, Djamali A. Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis. Transplant Rev (Orlando) 2008; 22: 1.
44. Mannon RB, Fairchild R. Allograft fibrosis-unmasking the players at the dance. Am J Transplant 2010; 10: 201.
45. Thiery JP, Acloque H, Huang RY, et al. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871.
46. Copeland JW, Beaumont BW, Merrilees MJ, et al. Epithelial-tomesenchymal transition of human proximal tubular epithelial cells: Effects of rapamycin, mycophenolate, cyclosporin, azathioprine, and methylprednisolone. Transplantation 2007; 83: 809.
47. Nankivell BJ, Chapman JR. Chronic allograft nephropathy: Current concepts and future directions. Transplantation 2006; 81: 643.
48. Haase VH. Oxygen regulates epithelial-to-mesenchymal transition: Insights into molecular mechanisms and relevance to disease. Kidney Int 2009; 76: 492.
49. Haase VH. Pathophysiological Consequences of HIF activation: HIF as a modulator of fibrosis. Ann NY Acad Sci 2009; 1177: 57.
50. Eddy AA. Molecular basis of renal fibrosis. Pediatr Nephrol 2000; 15: 290.
51. Haase VH. Hypoxia-inducible factors in the kidney. Am J Physiol Renal Physiol 2006; 291: F271.
52. Higgins DF, Kimura K, Iwano M, et al. Hypoxia-inducible factor signaling in the development of tissue fibrosis. Cell Cycle 2008; 7: 1128.
53. Tanaka T, Nangaku M. The role of hypoxia, increased oxygen consumption, and hypoxia-inducible factor-1 alpha in progression of chronic kidney disease. Curr Opin Nephrol Hypertens 2010; 19: 43.
54. Kimura K, Iwano M, Higgins DF, et al. Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis. Am J Physiol Renal Physiol 2008; 295: F1023.
55. Higgins DF, Kimura K, Bernhardt WM, et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 2007; 117: 3810.
56. Sun S, Ning X, Zhang Y, et al. Hypoxia-inducible factor-1alpha induces Twist expression in tubular epithelial cells subjected to hypoxia, leading to epithelial-to-mesenchymal transition. Kidney Int 2009; 75: 1278.
57. Rudnicki M, Perco P, Enrich J, et al. Hypoxia response and VEGF-A expression in human proximal tubular epithelial cells in stable and progressive renal disease. Lab Invest 2009; 89: 337.
58. Giraud S, Thuillier R, Belliard A, et al. Direct thrombin inhibitor prevents delayed graft function in a porcine model of renal transplantation. Transplantation 2009; 87: 1636.
59. Hauet T, Goujon JM, Vandewalle A, et al. Trimetazidine reduces renal dysfunction by limiting the cold ischemia/reperfusion injury in autotransplanted pig kidneys. J Am Soc Nephrol 2000; 11: 138.
60. Perrault LP, Aubin MC, Malo O, et al. Status of the endotheliumderived hyperpolarizing factor pathway in coronary arteries after heterotopic heart transplantation. J Heart Lung Transplant 2007; 26: 48.
61. Mueller PW, MacNeil ML, Steinberg KK. Stabilization of alanine aminopeptidase, gamma glutamyltranspeptidase, and N-acetylbeta-D-glucosaminidase activity in normal urines. Arch Environ Contam Toxicol 1986; 15: 343.
62. Grimm PC, Nickerson P, Gough J, et al. Computerized image analysis of Sirius Red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft function. J Am Soc Nephrol 2003; 14: 1662.